Studi Meta-analisis Hipertensi dan Diabetes Melitus Sebagai Faktor Risiko Penyakit Ginjal Kronis di Indonesia
on
Authors:
Maha Rani, Ida Bagus Putra Pramana, Anak Agung Gde Oka
Abstract:
“Indonesia is currently experiencing double burden of disease which Chronic Kidney Disease (CKD) is one of Indonesian disease burdens. Hypertension and Diabetes Mellitus are risk factors for CKD that have been widely studied, it is necessary to carry out a meta-analysis study in order to obtain stronger data and also could be used as a reference to prevent CKD. This study uses Systematic Review and Meta-analysis with RevMan 5.4.1. Estimated data using the Random Effect Model from 5 Case Control Studies with 781 case samples and 781 control samples. The OR for Hypertension for CKD was 5.28 (95% CI 1.46 - 19.09) while the OR for Diabetes Mellitus was 3.34 (95% CI 1.79 - 6.25). It can be interpreted that individuals with Hypertension have 5.28 times higher risk of experiencing CKD than non-Hypertensive individuals whereas individuals with Diabetes Mellitus have 3.34 times higher risk of developing CKD than individuals without Diabetes Mellitus.”
Keywords
Keyword Not Available
Downloads:
Download data is not yet available.
References
References Not Available
PDF:
https://jurnal.harianregional.com/eum/full-80236
Published
2022-09-22
How To Cite
RANI, Maha; PRAMANA, Ida Bagus Putra; OKA, Anak Agung Gde. Studi Meta-analisis Hipertensi dan Diabetes Melitus Sebagai Faktor Risiko Penyakit Ginjal Kronis di Indonesia.E-Jurnal Medika Udayana, [S.l.], v. 11, n. 9, p. 49-53, sep. 2022. ISSN 2303-1395. Available at: https://jurnal.harianregional.com/eum/id-80236. Date accessed: 08 Jul. 2024. doi:https://doi.org/10.24843/MU.2022.V11.i9.P10.
Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian
Issue
Vol 11 No 9 (2022): E-Jurnal Medika Udayana
Section
Articles
Copyright
This work is licensed under a Creative Commons Attribution 4.0 International License
Discussion and feedback